C07C 205/19
Having nitro groups bound to carbon atoms of six-membered aromatic rings and
Official title: having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms
C07C205/19 (Having nitro groups bound to carbon atoms of six-membered aromatic rings and) appears on 49 US grants and 19 published applications in this corpus.
Search patents in C07C- Granted patents
- 49
- Published applications
- 19
- Assignees
- 34
- Inventors
- 140
- Latest grant
- 14 May 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 2 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 3 |
| 2012 | 1 | 1 |
| 2013 | 1 | 0 |
| 2014 | 3 | 1 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods of preparing cytotoxic benzodiazepine derivatives14 May 2024US 11,981,687 B2ImmunoGen, Inc.
- Methods of preparing cytotoxic benzodiazepine derivatives19 Jul 2022US 11,390,633 B2ImmunoGen, Inc.
- Methods of preparing cytotoxic benzodiazepine derivatives24 Nov 2020US 10,844,078 B2ImmunoGen, Inc.
- Methods of preparing cytotoxic benzodiazepine derivatives20 Aug 2019US 10,385,071 B2ImmunoGen, Inc.
- Anti-viral compounds14 Apr 2015US 9,006,387 B2AbbVie Inc.
- Novel cannabinoid derivatives24 Jul 2025US 2025/0236578 A1Cannasoul Analytics Ltd.
- Process for Manufacturing Pibrentasvir Active Drug Substance13 Feb 2025US 2025/0051312 A1AbbVie Inc.
- Methods of preparing cytotoxic benzodiazepine derivatives9 Feb 2023US 2023/0039161 A1ImmunoGen, Inc.
- Process for Manufacturing Pibrentasvir Active Drug Substance10 Jun 2021US 2021/0171506 A1AbbVie Inc.
- Methods of preparing cytotoxic benzodiazepine derivatives13 May 2021US 2021/0139510 A1ImmunoGen, Inc.
Most cited
By later US patents
- Pharmacologically active catechol derivatives49US 5,446,194 AOrion-yhtyma Oy · 1995
- Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones44US 3,932,407 ABristol-Myers Company · 1976
- Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same33US 5,283,352 AOrion-yhtyma Oy · 1994
- Osmotic devices having vapor-permeable coatings31US 5,827,538 APfizer Inc. · 1998
- Insecticidal [1,1'-biphenyl]-3-ylmethyl esters27US 4,329,518 AFMC Corporation · 1982